Literature DB >> 8734951

Recrudescence induced by cyclophosphamide of chronic Trypanosoma cruzi infection in mice is influenced by the parasite strain.

M E Pereira1, L M Santos, M S Araújo, Z Brener.   

Abstract

Reactivation of chronic chagasic patients may occur upon use of immunosuppressive drugs related to kidney or heart transplantation or when they are affected by concomitant HIV infection. This recrudescence, however, does not occur in all chagasic patients exposed to immunosuppressive agents. We therefore investigated the influence of Trypanosoma cruzi strains in the recrudescence of the parasitism in mice at the chronic phase treated with cyclophosphamide, an immunosuppressor that blocks lymphocytes DNA synthesis and therefore controls B cells response. A large variation was detected in the percentages of newly established acute phases in the groups of mice inoculated with the different strains. We suggest that reactivation of chronic T. cruzi infections is influenced by the parasite intrinsic characteristics, a phenomenon that might occur in the human disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734951     DOI: 10.1590/s0074-02761996000100011

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

1.  Low-Level Parasite Persistence Drives Vasculitis and Myositis in Skeletal Muscle of Mice Chronically Infected with Trypanosoma cruzi.

Authors:  Joseph D Weaver; Victoria J Hoffman; Ester Roffe; Philip M Murphy
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Influence of Trypanosoma cruzi chronic infection in the depletion of esophageal neurons in Calomys callosus.

Authors:  Leony Cristina Caetano; Sérgio Zucoloto; Laura Midori Kawasse; Miriam Paula Alonso Toldo; José Clóvis Júnior do Prado
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 3.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

4.  A DTU-dependent blood parasitism and a DTU-independent tissue parasitism during mixed infection of Trypanosoma cruzi in immunosuppressed mice.

Authors:  Helioswilton Sales-Campos; Henrique Borges Kappel; Cristiane Pontes Andrade; Tiago Pereira Lima; Mardén Estevão Mattos; Alessandra de Castilho; Dalmo Correia; Luis Eduardo Ramirez Giraldo; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2013-11-01       Impact factor: 2.289

5.  Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression.

Authors:  Noemi Nosomi Taniwaki; Viviane Martinelli Gonçalves; Julianna Kesselring Romero; Claudio Vieira da Silva; Solange da Silva; Renato Arruda Mortara
Journal:  Parasitol Res       Date:  2011-02-18       Impact factor: 2.289

6.  Disruption of myofibrillar proteins in cardiac muscle of Calomys callosus chronically infected with Trypanosoma cruzi and treated with immunosuppressive agent.

Authors:  Noemi N Taniwaki; Walter K Andreoli; Kátia S Calabrese; Solange da Silva; Renato A Mortara
Journal:  Parasitol Res       Date:  2005-08-02       Impact factor: 2.289

Review 7.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

8.  Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.

Authors:  V Michailowsky; S M Murta; L Carvalho-Oliveira; M E Pereira; L R Ferreira; Z Brener; A J Romanha; R T Gazzinelli
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  Chagas disease and HIV co-infection: genetic analyses of two Trypanosoma cruzi strains under experimental immunosuppression.

Authors:  Célia M Marques De Brito; Marize Q Pires; Raquel S Pacheco
Journal:  Kinetoplastid Biol Dis       Date:  2003-10-28

10.  Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy.

Authors:  Daniela N Silva; Bruno S F Souza; Juliana F Vasconcelos; Carine M Azevedo; Clarissa X R Valim; Bruno D Paredes; Vinicius P C Rocha; Gisele B Carvalho; Pamela S Daltro; Simone G Macambira; Carolina K V Nonaka; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.